Paradoxically, ACE2 also exhibits tumor‐suppressive properties by inhibiting angiogenesis and modulating the tumor microenvironment, leading to improved patient prognoses in some cancers like breast cancer. The gene discussed is ACE2; the disease is breast carcinoma.